Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium by Steven Simoens, Andre Bento-Abreu, Barbara Merckx, Sophie Joubert, Steve Vermeersch, Andrew Pavelyev, Andrew Pavelyev, Stefan Varga, Edith Morais

Connect to this object online.

Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland by André B. Kind, Andrew Pavelyev, Smita Kothari, Nadia El Mouaddin, Aurélie Schmidt, Edith Morais, Patrik Guggisberg, Florian Lienert

Connect to this object online.

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong by Tak Hong Cheung, Sally Shuk Yee Cheng, Danny Hsu, Queenie Wing-Lei Wong, Andrew Pavelyev, Isaya Sukarom, Kunal Saxena

Connect to this object online.

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic model... by Dr Prof Marc Brisson, PhD, Élodie Bénard, MSc, Mélanie Drolet, PhD, Johannes A Bogaards, PhD, Iacopo Baussano, MD, Simopekka Vänskä, PhD, Mark Jit, PhD, Prof Marie-Claude Boily, PhD, Megan A Smith, MPH, Johannes Berkhof, PhD, Prof Karen Canfell, PhD, Harrell W Chesson, PhD, Emily A Burger, PhD, Yoon H Choi, PhD, Prof Birgitte Freiesleben De Blasio, PhD, Sake J De Vlas, PhD, Giorgio Guzzetta, PhD, Jan A C Hontelez, PhD, Johannes Horn, Dipl Biomath, Martin R Jepsen, PhD, Prof Jane J Kim, PhD, Fulvio Lazzarato, MSc, Suzette M Matthijsse, MSc, Rafael Mikolajczyk, MD, Andrew Pavelyev, PhD, Matthew Pillsbury, PhD, Leigh Anne Shafer, PhD, Stephen P Tully, PhD, Hugo C Turner, PhD, Cara Usher, PhD, Prof Cathal Walsh, PhD

Connect to this object online.